Cell Envelope Integrity and Capsule Characterization of Rhodotorula mucilaginosa Strains from Clinical and...

Area of Science:

• Medical Mycology
• Fungal Pathogenesis
• Immunocompromised Host Infections

Background:

• Rhodotorula yeasts, including Rhodotorula mucilaginosa, are increasingly recognized as opportunistic pathogens, especially in immunocompromised patients.
• Phenotypic variability and the role of the capsule in Rhodotorula infections are poorly understood, unlike the well-studied Cryptococcus neoformans.
• Limited antifungal treatment options and emerging drug resistance in clinical Rhodotorula isolates necessitate further research into fungal biology.

Purpose of the Study:

• To investigate phenotypic variability between clinical and environmental strains of Rhodotorula mucilaginosa.
• To compare the cell envelope characteristics and capsule size of R. mucilaginosa with Cryptococcus neoformans.
• To develop a specific diagnostic reagent for Rhodotorula species.

Main Methods:

• Comparative analysis of 16 Rhodotorula mucilaginosa strains (8 clinical, 8 environmental) and 6 Cryptococcus neoformans strains.
• Phenotypic characterization including growth on challenging media, urease and melanin production, India ink staining for capsule size, and antifungal susceptibility testing.
• Generation and characterization of an anticapsular antibody (Rh1) for Rhodotorula specificity.
• Cell surface probe binding assays (WGA, ConA, CFW, EY) to assess cell wall composition.

Main Results:

• R. mucilaginosa strains exhibited phenotypic differences, suggesting variations in cell wall composition, signaling pathways, or membrane susceptibility compared to C. neoformans.
• All R. mucilaginosa strains produced urease but not melanin; clinical isolates had larger capsules than environmental ones, though generally smaller than C. neoformans.
• All R. mucilaginosa strains were resistant to fluconazole, and most were resistant to voriconazole; an anticapsular antibody (Rh1) demonstrated specificity for Rhodotorula species.
• Cell surface probe data indicated potentially more accessible chitin in R. mucilaginosa, but lower overall chitooligomer abundance compared to C. neoformans.

Conclusions:

• Rhodotorula mucilaginosa displays significant phenotypic variability, impacting its interaction with host defenses and antifungal treatments.
• The generated anticapsular antibody (Rh1) is a novel and specific tool for identifying Rhodotorula species.
• Understanding R. mucilaginosa cell envelope composition and variability is crucial for developing effective diagnostic and therapeutic strategies against these emerging fungal pathogens.